Subjective, physiological, and cognitive responses to intravenous nicotine: Effects of sex and menstrual cycle phase

Neuropsychopharmacology

Volumn 39, Issue 6, 2014, Pages 1431-1440

  DeVito, Elise E ^a   Herman, Aryeh I ^a,b   Waters, Andrew J ^c   Valentine, Gerald W ^a,b   Sofuoglu, Mehmet ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

addiction; estradiol; menstrual cycle; nicotine; progesterone; sex differences

Indexed keywords

ESTRADIOL; NICOTINE; PROGESTERONE; NICOTINIC AGENT;

ADULT; AFFECT; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; ADOLESCENT; DOSE RESPONSE; DRUG EFFECTS; DRUG SEEKING BEHAVIOR; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SMOKING; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AFFECT; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SEX FACTORS; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84900816045     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.339     Document Type: Article

References (49)

1. al'Absi M, Amunrud T, Wittmers LE (2002). Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers. Pharmacol Biochem Behav 72: 707-716. (Pubitemid 34450869)
2. Allen AM, Allen SS, Widenmier J, Al'absi M (2009). Patterns of cortisol and craving by menstrual phase in women attempting to quit smoking. Addict Behav 34: 632-635.
3. Allen SS, Bade T, Center B, Finstad D, Hatsukami D (2008a). Menstrual phase effects on smoking relapse. Addiction 103: 809-821. (Pubitemid 351537675)
4. Allen SS, Bade T, Hatsukami D, Center B (2008b). Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine Tob Res 10: 35-45.
5. Anker JJ, Carroll ME (2011). Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci 8: 73-96.
6. Benowitz N, Ahijevych K, Jarvis MJ, LeHouezec J, Lichtenstein E, Henningfield JE et al (2002). Biochemical verification of tobacco use and cessation. Report from the SRNT Subcommittee on Biochemical Verification. Nicotine Tob Res 4: 149-159.
7. Benowitz NL, Hatsukami D (1998). Gender differences in the pharmacology of nicotine addiction. Addict Biol 3: 383-404. (Pubitemid 28461408)
8. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd (2006). Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 79: 480-488.
9. Carpenter MJ, Saladin ME, Leinbach AS, Larowe SD, Upadhyaya HP (2008). Menstrual phase effects on smoking cessation: a pilot feasibility study. J Womens Health (Larchmt) 17: 293-301. (Pubitemid 351631248)
10. Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT (2006). Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine Tob Res 8: 627-638. (Pubitemid 44480412)
11. Cepeda-Benito A, Reynoso JT, Erath S (2004). Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol 72: 712-722. (Pubitemid 38988848)
12. Cox LS, Tiffany ST, Christen AG (2001). Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3: 7-16. (Pubitemid 32611534)
13. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ et al (2009). The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 6: e1000058.
14. DeBon M, Klesges RC, Klesges LM (1995). Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addict Behav 20: 335-343.
15. Evans SE, Blank M, Sams C, Weaver MF, Eissenberg T (2006). Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol 14: 121-135. (Pubitemid 43988630)
16. First MB, Spitzer RL, Gibbon M, Williams JB (1996). Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition. Biometrics Research Department, New York State Psychiatric Institution: New York.
17. Franklin TR, Allen SS (2009). Influence of menstrual cycle phase on smoking cessation treatment outcome: a hypothesis regarding the discordant findings in the literature. Addiction 104: 1941-1942.
18. Franklin TR, Ehrman R, Lynch KG, Harper D, Sciortino N, O'Brien CP et al (2008). Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) 17: 287-292. (Pubitemid 351631249)
19. Hughes JR, Hatsukami D (1986). Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43: 289-294. (Pubitemid 16052281)
20. Hukkanen J, Gourlay SG, Kenkare S, Benowitz NL (2005). Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine. Clin Pharmacol Ther 77: 159-169. (Pubitemid 40269131)
21. Justice AJ, de Wit H (1999). Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 145: 67-75. (Pubitemid 29339764)
22. Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB (2007). Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol 15: 21-36.
23. Lynch WJ, Roth ME, Carroll ME (2002). Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berl) 164: 121-137. (Pubitemid 36015575)
24. Marks JL, Pomerleau CS, Pomerleau OF (1999). Effects of menstrual phase on reactivity to nicotine. Addict Behav 24: 127-134. (Pubitemid 29021874)
25. Masson CL, Gilbert DG (1999). Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers. J Behav Med 22: 589-604. (Pubitemid 30041720)
26. Mazure CM, Toll B, McKee SA, Wu R, O'Malley SS (2011). Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug Alcohol Depend 114: 68-72.
27. Mendelson JH, Sholar MB, Goletiani N, Siegel AJ, Mello NK (2005). Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology 30: 1751-1763. (Pubitemid 43086032)
28. Merritt PS, Cobb AR, Cook GI (2012). Sex differences in the cognitive effects of tobacco abstinence: a pilot study. Exp Clin Psychopharmacol 20: 258-263.
29. Munafo M, Bradburn M, Bowes L, David S (2004). Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res 6: 769-776. (Pubitemid 39504451)
30. Myers CS, Taylor RC, Moolchan ET, Heishman SJ (2008). Doserelated enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacology 33: 588-598.
31. Netter P, Muller MJ, Neumann A, Kamradik B (1994). The influence of nicotine on performance, mood, and physiological parameters as related to smoking habit, gender, and suggestibility. Clin Investig 72: 512-518. (Pubitemid 24253417)
32. O'Hara P, Portser SA, Anderson BP (1989). The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women. Addict Behav 14: 595-600. (Pubitemid 20049856)
33. Perkins KA (2009a). Discriminative stimulus effects of nicotine in humans. Handb Exp Pharmacol 192: 369-400.
34. Perkins KA (2009b). Sex differences in nicotine reinforcement and reward: influence on the persistence of tobacco smoking. Nebr Symp Motiv 55: 143-169.
35. Pickworth WB, Fant RV (1998). Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. Psychoneuroendocrinology 23: 131-141. (Pubitemid 28248467)
36. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF (1994). Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict Behav 19: 33-39. (Pubitemid 24072190)
37. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG (1992). The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology 17: 627-638. (Pubitemid 23043125)
38. Reeves D, Winter K, Kane R, Elsmore T, Bleiberg J (2002). ANAM 2001's User's Manual. National Cognitive Recovery Foundation.
39. Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ (2012). Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol 20: 251-257.
40. Sofuoglu M, Babb DA, Hatsukami DK (2001). Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Behav 69: 299-304. (Pubitemid 32566275)
41. Sofuoglu M, Dudish-Poulsen S, Nelson D, Pentel PR, Hatsukami DK (1999). Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol 7: 274-283. (Pubitemid 29399031)
42. Sofuoglu M, Herman AI, Nadim H, Jatlow P (2012). Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine. Neuropsychopharmacology 37: 1509-1516.
43. Sofuoglu M, Mitchell E, Kosten TR (2004). Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav 78: 699-705. (Pubitemid 39037728)
44. Sofuoglu M, Mitchell E, Mooney M (2009). Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol 24: 559-564.
45. Sofuoglu M, Mooney M (2009). Subjective responses to intravenous nicotine: greater sensitivity in women than in men. Exp Clin Psychopharmacol 17: 63-69.
46. Sofuoglu M, Mouratidis M, Mooney M (2011). Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology 36: 123-132.
47. Sofuoglu M, Yoo S, Hill KP, Mooney M (2008). Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacology 33: 715-720. (Pubitemid 351252695)
48. USDHHS (2001). Women and Smoking: A Report of the Surgeon General.
49. Watson D, Clark LA, Tellegen A (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54: 1063-1070.